Canada - English - Health Canada

sifi s.p.a. - netilmicin (netilmicin sulfate); dexamethasone (dexamethasone sodium phosphate) - solution - 0.3%; 0.1% - netilmicin (netilmicin sulfate) 0.3%; dexamethasone (dexamethasone sodium phosphate) 0.1% - antibacterials

Canada - English - Health Canada

sifi s.p.a. - netilmicin (netilmicin sulfate); dexamethasone (dexamethasone sodium phosphate) - solution - 0.3%; 0.1% - netilmicin (netilmicin sulfate) 0.3%; dexamethasone (dexamethasone sodium phosphate) 0.1% - antibacterials

United States - English - NLM (National Library of Medicine)

rebel distributors corp - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - tobramycin 3 mg in 1 g - tobradex (tobramycin and dexamethasone ophthalmic ointment) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacte

United States - English - NLM (National Library of Medicine)

stat rx usa llc - tobramycin (unii: vz8rrz51vk) (tobramycin - unii:vz8rrz51vk), dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql) - tobramycin 3 mg in 1 ml - tobradex® (tobramycin and dexamethasone ophthalmic suspension) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common ba

Canada - English - Health Canada

novartis pharmaceuticals canada inc - tobramycin; dexamethasone - ointment - 0.3%; 0.1% - tobramycin 0.3%; dexamethasone 0.1% - antibacterials

Canada - English - Health Canada

novartis pharmaceuticals canada inc - tobramycin; dexamethasone - suspension - 0.3%; 0.1% - tobramycin 0.3%; dexamethasone 0.1% - antibacterials

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

lincoln pharmaceuticals limited, india - dexamethasone , gentamycin - eye/ear drop - 0,01+0.03

Ireland - English - HPRA (Health Products Regulatory Authority)

schering plough limited - gentamicin sulfate betamethasone valerate clotrimazole - ear drops suspension - canine - antibacterial

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - dexamethasone; framycetin sulfate; gramicidin -

Israel - English - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole; dexamethasone acetate; neomycin sulfate - cream - clotrimazole 1 %; neomycin sulfate 0.645 %; dexamethasone acetate 0.044 % - combinations - combinations - treatment of dermatitis involving also a bacterial and/or fungal infection.